This invention relates generally to artificial hearts, and more particularly to methods of control therefor.
Heart transplant is a course of action for patients with end stage heart failure, a leading cause of premature death. Because of the unavailability of donor hearts, electromechanical blood pumping systems are being developed and are increasingly coming into use. These devices can provide a bridge to transplant, bridge to recovery, or as a permanent treatment for patients who may not receive a donor heart. Most such patients will be treated with a ventricular assist device (“VAD”), which draws blood from the left or right ventricle, and discharges to the aorta or pulmonary artery, respectively. Some patents require a total artificial heart (TAH) as either a bridge to transplant, or as a permanent therapy.
One known type of TAH is a continuous flow total artificial heart (CFTAH) which includes two centrifugal pumps on one rotor supported on a hydrodynamic bearing and driven by a single motor. The CFTAH replaces the ventricles of the heart, and delivers blood flow to both the systemic (left) and pulmonary (right) circulation of the patient. An example of such a CFTAH is described in U.S. Patent Application Publication 2007/0253842.
While this type of CFTAH can be operated under external control, there is a need for physiologic control therefor, preferably using the least number of sensors.
This need is addressed by the present invention, which provides a system and method for physiologic control of an artificial heart.
According to one aspect of the invention, a method is provided of controlling a pump including a electrical motor coupled to a rotor which carries first and second impellers at opposite ends thereof, the method including: (a) driving the rotor using the motor, so as to circulate fluid from the first impeller through a first fluid circuit, the second impeller, a second fluid circuit, and back to the first impeller; (b) sensing electrical power delivered to the motor and determining a resistance of the first fluid circuit, based on a first motor parameter which is a function of the electrical power delivered to the motor; (c) determining a flow rate through the first fluid circuit based on a second motor parameter which is a function of the electrical power delivered to the motor; and (d) varying at least one operational parameter of the pump so as to maintain a predetermined relationship between the flow rate and the resistance of the first fluid circuit.
According to another aspect of the invention, an artificial heart system includes: (a) an artificial heart including a electrical motor coupled to a rotor which carries first and second impellers at opposite ends thereof, where: (i) the first impeller communicates with a patient's systemic vasculature; and (ii) the second impeller communicates with the patient's pulmonary vasculature; (b) a power source; and (c) a controller coupled to the power source and the pump, the controller programmed to: (i) drive the rotor using the motor, so as to circulate blood from the first impeller through the systemic vasculature, the second impeller, the pulmonary vasculature, and back to the first impeller; (ii) sense electrical power delivered to the motor and determine a resistance of the systemic vasculature, based on a first motor parameter which is a function of the electrical power delivered to the motor; (iii) determine a flow rate through the systemic vasculature based on a second motor parameter which is a function of the electrical power delivered to the motor; and (iii) vary at least one operational parameter of the artificial heart so as to maintain a predetermined relationship between the systemic flow and the resistance of the systemic vasculature.
According to another aspect of the invention, a method is provided for controlling a pump including a electrical motor coupled to a rotor which carries first and second impellers at opposite ends thereof. The method includes: (a) driving the rotor using the motor, so as to circulate fluid from the first impeller through a first fluid circuit, the second impeller, a second fluid circuit, and back to the first impeller; (b) modulating the speed of the rotor to generate a pulsatile flow; (c) monitoring a motor parameter indicative of suction or rubbing; and (d) in response to an indication of suction or rubbing, reducing the peak motor speed.
The invention may be best understood by reference to the following description taken in conjunction with the accompanying drawing figures in which:
Referring to the drawings wherein identical reference numerals denote the same elements throughout the various views,
A rotor 20 is disposed inside the stator 18. The rotor 20 includes a magnet assembly 22 comprising one or more permanent magnets arranged in an annular configuration. A left impeller 24 comprising an annular array of vanes is carried at the left end of the rotor 20 adjacent the left inlet 14. A right impeller 26 comprising an annular array of vanes is carried at the right end of the rotor 20 adjacent the right inlet 16. The left and right impellers 24 and 26 discharge into separate right and left peripheral outlets, which are not shown in
All of the portions of the artificial heart 10 which will come into contact with blood or tissue are constructed from known biologically compatible materials such as titanium, medical grade polymers, and the like.
The rotor 20 and the stator 18 operate as a brushless DC motor through the application of varying electrical currents to the stator 18. The artificial heart 10 is coupled by a cable 28 to a controller 32, which is in turn powered by a power source 30, for example a battery, both of which are shown schematically in
If the systemic (i.e. left) flow is lower than the pulmonary (i.e. right) flow, then the left atrial pressure increases, and the right atrial pressure decreases. If the left output is greater than the right, then the atrial pressures reverse. Thus, an unbalance in flows is automatically accompanied by an unbalance in atrial (pump inlet) pressures.
The magnet assembly 22 in the rotor 20 is axially shorter than the stator 18, allowing a degree of free axial movement of the rotor 20, in response to any unbalance of pump inlet (i.e. atrial) pressures. This axial movement changes the distances “D1” and “D2” (see
The artificial heart 10 is controlled as follows. First, a desired or targeted characteristic is determined by a physician. The characteristic describes the relationship between the volumetric flow rate in the systemic vasculature S and the SVR. In the example shown in
Referring to
Next, at block 110, the controller 32 computes two parameters: PSnorm, which is defined as average Watts divided by kRPM3, and PQnorm, defined as average Watts divided by kRPM2. Because these parameters are derived from or related to the power delivered to the motor using mathematical expressions, they may be described as being “functions of” power delivered to the motor.
Next, at block 120, the SVR and the systemic flow rate are determined based on the computed parameters.
Once the systemic flow rate and SVR have been determined, their relationship can be computed to determine if the current operating point lies on the prescribed characteristic shown in
Independent of the control process, the self-balancing process described above is also taking place during operation of the artificial heart 10. The relative left/right performance of the two pumps can be further affected by the relative impedance seen by the pump outputs. In this pump configuration, speed modulation at high SVR can decrease the left pump output while increase the right pump output. This effect can be moderated by using the controller 32 to reduce or eliminate any speed pulsatility at high SVR values. For example, the controller 32 may be programmed to follow a characteristic of enforced speed pulsatility vs. SVR similar to the example shown in
Operating the artificial heart 10 in a modulated mode can cause an intermittent suction of tissue around one of the left or right inlets 14 or 16 at the cyclic peak speed with physiologic decreases in blood volume returning to the artificial heart 10. This intermittent occlusion can cause erratic and amplified oscillation in axial movement of the rotor 20, and touching of the left or right impellers 24 or 26 against the pump housing 12, which is reflected in the speed and current signals processed in the controller 32. Intermittent suction and the associated effects are undesirable and can cause excessive wear or damage to the artificial heart 10. In addition to control of the artificial heart 10, the present invention provides a method for detecting this intermittent suction and responding to it through peak speed reduction.
Normally, when the speed is a sinusoidal speed wave form, this will yield a current of a similar wave form, and vice-versa. An example of normal system response is shown in
Another suitable test for triggering peak speed reduction is analysis of normalized current.
Regardless of which specific trigger or limit value is used to determine the presence of suction and/or rubbing, the controller 32 may be programmed to evaluate the parameter and look for the specified trigger and/or compare the parameter to the predetermined limit. If suction or rubbing is indicated, the controller 32 responds by reducing the peak speed. This can be done by lowering the mean speed, reducing the speed modulation amplitude, changing the duty cycle (portion of time at high speed), or any combination thereof.
The foregoing has described a method of operating a total artificial heart. While specific embodiments of the present invention have been described, it will be apparent to those skilled in the art that various modifications thereto can be made without departing from the spirit and scope of the invention. Accordingly, the foregoing description of the preferred embodiment of the invention and the best mode for practicing the invention are provided for the purpose of illustration only and not for the purpose of limitation.
Number | Date | Country | |
---|---|---|---|
Parent | 12349658 | Jan 2009 | US |
Child | 14187615 | US |